Our article on crypto drug candidate out in Nature today


Very happy to see a terrific collaboration with NITD and Washington State published today. The paper describes new transgenic models to evaluate treatments for cryptosporidiosis and the discovery of Kdu731 a potent PI4K inhibitor. Better treatments for children suffering from diarrhea are urgently needed and we hope that this study will represent a breakthrough towards that goal. We thank NIH and Wellcome Trust for financial support of the work.

Read the paper, and press releases at UGA and Wellcome Trust.

Featured Posts
Posts are coming soon
Stay tuned...
Recent Posts
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square